TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05488275

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: MPFL reconstruction

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: MPFL reconstruction
Study: NCT00538928

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lung protective ventilation
Description: tidal volume 6 ml/kg ideal body weight

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: lung protective ventilation
Description: tidal volume 6 ml/kg ideal body weight
Study: NCT01540214

Intervention type: OTHER
Intervention: Pre- and postoperative evaluations
Description: At baseline before surgery and at 6 and 12 months after surgery: questionnaires, bladder diary, pelvic examination with additional ultrasound (one extra outpatient clinic visit at 6 months compared to standard care).~At baseline before surgery and at 12 months after surgery: urodynamics with additional urine sampling (one extra outpatient clinic visit at 12 months compared to standard care).~At time of surgery: additional cystoscopy.
Study: NCT00871650

Intervention type: OTHER
Intervention: Sleep data recording
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.

Intervention type: OTHER
Intervention: Sleep data recording
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.

Intervention type: OTHER
Intervention: PET scan - waking
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.

Intervention type: OTHER
Intervention: PET scan - waking
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.

Intervention type: OTHER
Intervention: PET scan - REM Sleep
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.

Intervention type: OTHER
Intervention: PET scan - REM Sleep
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.
Study: NCT02440347

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Computer controlled anesthetic delivery by Anaeject
Description: Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by computer controlled local anesthetic delivery system (Anaeject).

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional anesthetic delivery by carpule syringe
Description: Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by conventional syringe (carpule syringe).
Study: NCT02012062

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TPF neoadjuvant chemotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPF neoadjuvant chemotherapy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Concurrent chemotherapy with cisplatin during radiotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Concurrent nimotuzumab during radiotherapy

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radical radiotherapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radical radiotherapy
Study: NCT00782496

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Education + new meter
Description: Diabetes education and a new meter with basic features

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Education + new meter + feature activation
Description: Diabetes education and a new meter with advanced features
Study: NCT04410068

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WARMTAC
Description: Randomization to one of the arms previous to surgery.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3M Bair Hugger
Description: Randomization to one of the arms previous to surgery.
Study: NCT03703583

Intervention type: OTHER
Intervention: There is no intervention in this observational study.
Description: There is no intervention in this observational study.

Intervention type: OTHER
Intervention: There is no intervention in this observational study.
Description: There is no intervention in this observational study.
Study: NCT00878202

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SCAD information system
Description: Clinical follow-up and continuation of therapeutic education by telemedicine during 3 months
Study: NCT00749307

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT03055481

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High irradiance level of phototherapy
Description: High irradiance level of phototherapy: the target irradiance level is 30-35uW per square centimeter per nanometer of wavelength.
Study: NCT02138266

Intervention type: DEVICE
Intervention: Topcon Specular Microscope SP-1P

Intervention type: DEVICE
Intervention: Topcon Specular Microscope SP-1P

Intervention type: DEVICE
Intervention: Topcon Specular Microscope SP-1P

Intervention type: DEVICE
Intervention: Konan Specular Microscope CELLCHEK XL

Intervention type: DEVICE
Intervention: Konan Specular Microscope CELLCHEK XL
Study: NCT03055481

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low irradiance level of phototherapy
Description: Low irradiance level of phototherapy: the target irradiance level is 12-15uW per square centimeter per nanometer of wavelength
Study: NCT03687398

Intervention type: DIAGNOSTIC_TEST
Intervention: genetic testing with nanoclonal technique
Description: endometrial sampling
Study: NCT02138266

Intervention type: DEVICE
Intervention: Konan Specular Microscope CELLCHEK XL
Study: NCT00462137

Intervention type: PROCEDURE
Intervention: Sleep Studies
Study: NCT02551770

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling and root planing
Description: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Scaling and root planing without Emdogain
Description: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Emdogain application
Description: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw
Study: NCT03979053

Intervention type: DEVICE
Intervention: Multiparametric MRI Scan
Description: Patients attending the clinic will have a MRI scan added to their standard of care.
Study: NCT03575338

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open Scarf Osteotomy
Description: Open Scarf Osteotomy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive scarf Osteotomy
Description: Minimally invasive scarf Osteotomy
Study: NCT03129048

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MedDiet
Description: Research subjects will be randomly assigned to one of three intervention groups.~The MedDiet-A group will learn about and how to adhere to the Mediterranean Diet. Over the course of 8 months, they will receive twenty-two classes 60-minute in length.~The MedDiet-WL group will learn about the Mediterranean Diet, how to adhere to is and engage in lifestyle choices like exercising and eating fewer calories so that they will loose weight. Over the course of 8 months they will receive 22 classes, each 90 minutes in length.~The Typical Diet Control group will be asked to maintain current eating and activity patterns over the course of the 14 month study.
Study: NCT02895113

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Patients suffering from type 2 diabetes will be randomized to receive 100 mg/day or placebo for one year
Study: NCT03684356

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: socket shield technique
Description: immediate implant placement with buccal part of the root is retained

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: xenograft
Description: immediate implant placement with filling the buccal gap with xenograft
Study: NCT03208426

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dibismuth trioxide 120mg (BQ10)
Description: KCB F.C. TABLETS, dibismuth trioxide 120mg qid for 10 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole (BQ10)
Description: Flagyl, metronidazole 500mg tid for 10 days
Study: NCT03129048

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: MedDiet
Description: Research subjects will be randomly assigned to one of three intervention groups.~The MedDiet-A group will learn about and how to adhere to the Mediterranean Diet. Over the course of 8 months, they will receive twenty-two classes 60-minute in length.~The MedDiet-WL group will learn about the Mediterranean Diet, how to adhere to is and engage in lifestyle choices like exercising and eating fewer calories so that they will loose weight. Over the course of 8 months they will receive 22 classes, each 90 minutes in length.~The Typical Diet Control group will be asked to maintain current eating and activity patterns over the course of the 14 month study.
Study: NCT03453528

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-PSMA
Description: 68Ga-PSMA will be injected intravenously via an indwelling catheter in an antecubital vein; (68Ga-PSMA activity: min 100 MBq - max 200 MBq, weighted activity: 2.0 MBq/Kg).
Study: NCT02895113

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients in this arm will be treated with placebo
Study: NCT02881489

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biological: Cell-based therapy
Description: Human autologous bone marrow-derived mesenchymal stem cell transplantation in ALS patients.
Study: NCT04557826

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RD19
Description: Experimental device that uses safe electromagnetic energy to stimulate the proximal repository of respiratory tract infectious disease pathogens
Study: NCT01237795

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dentifrice
Description: Dentifrices (4 formulations) used as auxiliary agents for brushing complete dentures.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dentifrice
Description: Dentifrices (4 formulations) used as auxiliary agents for brushing complete dentures.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dentifrice
Description: Dentifrices (4 formulations) used as auxiliary agents for brushing complete dentures.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dentifrice
Description: Dentifrices (4 formulations) used as auxiliary agents for brushing complete dentures.
Study: NCT03402516

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 18.5 resector
Description: hysteroscopic myomectomy with a 18.5 Fr resector after cervical dilatation until Hegar bougie number 7

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 26Fr resector
Description: hysteroscopic myomectomy with a 26Fr resector after cervical dilatation until Hegar bougie number 10
Study: NCT01017276

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP1585
Description: oral
Study: NCT04066205

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SLEEPSAMRT
Description: SLEEPSMART is a web-based intervention that adapted and modified components from the Transdiagnostic Sleep and Circadian intervention for youth and included four cross-cutting components (sleep complaint, education, behavior change and motivation, and goal-setting) that were integrated into each module. To begin the intervention, participants were provided a link to the SLEEPSMART intervention website for one of the above modules and an online sleep coach each week. At the end of each week, children and parents uploaded the weekly activities and goals via the REDCap link and set up a meeting with the sleep coach to review. The modules took 20 to 30 minutes to complete.
Study: NCT00682643

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluticasone furoate nasal spray
Description: fluticasone furoate nasal spray

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: vehicle placebo nasal spray
Description: placebo
Study: NCT01875185

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg
Description: Aspirin 81 mg orally daily for 7 days
Study: NCT04166526

Intervention type: DEVICE
Intervention: FDNIRS-DCS
Description: FDNIRS-DCS measurements will be performed at the same time as all MRI scans. Participants in Group 4 will have additional measurements before, during, and after the their scheduled transfusion.
Study: NCT03208426

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tetracycline (BQ10)
Description: Tetracycline (Brand name: Tetracycline Capsule ) 500mg qid for 10 days
Study: NCT00743197

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: Aspirin 81 mg daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lisinopril
Description: Lisinopril 10 mg every night

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Simvastatin
Description: Simvastatin 20 mg every night

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lovaza
Description: Lovaza 1 gram daily

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic Lifestyle Changes
Description: Therapeutic lifestyle changes will be initiated with the assistance of a dietician, including diet counseling, exercise recommendation, and weight maintenance/weight loss.
Study: NCT04954014

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Patients will receive best available treatment (BAT) for COVID-19 plus a single dose of bevacizumab calculated as 7,5 mg/kg diluted in 250cc of saline solution during 90 minutes.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BAT
Description: Patients will receive best available treatment for COVID-19.
Study: NCT02277457

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PET-Adaptive RT
Description: All patients will be treated with response-driven PET-adaptive RT. The radiation dose will be delivered in greater than or equal to 2.2 Gy per daily fraction to FDG-PET/CT-guided target volumes with the treatment duration limited to 30 fractions and total radiation dose limited to 66-80.4 Gy.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PET-Adaptive RT
Description: All patients will be treated with response-driven PET-adaptive RT. The radiation dose will be delivered in greater than or equal to 2.2 Gy per daily fraction to FDG-PET/CT-guided target volumes with the treatment duration limited to 30 fractions and total radiation dose limited to 66-80.4 Gy.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erlotinib
Description: 150 mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Crizotinib
Description: 250 mg twice daily
Study: NCT02304120

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive postural training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treadmill training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: All participating patients will attend usual care according to their treatment plan (taking part in the study does not affect the treatment plan). A physiotherapy referral requests 9 treatments, each of which takes 30 minutes. These will take place twice a week for 4.5 weeks. The study protocol does not dictate the content of the physiotherapy sessions themselves, but detailed documentation of provided treatments is required (therapy documentation sheet). Additionally, the aim of the physiotherapy sessions should always include reduction of muscular imbalances and optimisation of posture.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy
Description: All participating patients will attend usual care according to their treatment plan (taking part in the study does not affect the treatment plan). A physiotherapy referral requests 9 treatments, each of which takes 30 minutes. These will take place twice a week for 4.5 weeks. The study protocol does not dictate the content of the physiotherapy sessions themselves, but detailed documentation of provided treatments is required (therapy documentation sheet). Additionally, the aim of the physiotherapy sessions should always include reduction of muscular imbalances and optimisation of posture.
Study: NCT03249181

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dolutegravir
Description: Patients randomized to the study drug will be commenced on an antiretroviral regimen comprising DTG 50mg once daily in combination with 2 NRTIs

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (EFV + 2 NRTI backbone)
Description: Patients randomized to receive standard of care will receive the currently used antiretroviral regimens in keeping with national policy.
Study: NCT00720486

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Juvenile Justice Anger Management (JJAM) for Girls
Description: JJAM will include two 1.5-hour group treatment sessions per week for 8 weeks. JJAM sessions will be manual based and will be designed to help youth develop skills in the following areas: identifying different types of physical and relational aggression, recognizing early warning signs of anger, avoiding anger-provoking situations, managing anger to prevent aggression, solving problems, communicating about anger-related events, and repairing relationships damaged by anger-related behaviors.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: Treatment as usual will include standard activities in the female juvenile justice program.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Treatment as usual will include standard activities in the female juvenile justice program.
Study: NCT03259581

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Transarterial chemoembolization
Description: Delivery of lipiodol, chemotherapy (Deoxyrubicin), and particles (embosphere particles) to the arteries feeding hepatocellular carcinoma. While both chemotherapy and particles are delivered this is a single procedure in which the chemotherapy is delivered followed immediately by particles.
Study: NCT03467477

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flortaucipir F18
Description: 370 megabecquerel (MBq) IV single-dose

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Brain PET Scan
Description: positron emission tomography (PET) scan of the brain
Study: NCT03632174

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical Ointment with L. reuteri
Description: Topical Ointment containing live Lactobacillus reuteri DSM17938 applied twice daily in dry areas of the entire body

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical Ointment without L. reuteri
Description: Topical Ointment that does not contain Lactobacillus reuteri DSM17938 applied twice daily in dry areas of the entire body
Study: NCT03317197

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control Group
Description: Using Epinephrine(1 mg/cardiopulmonary resuscitation(CPR) cycle) only

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Experimental Group 1
Description: Using Epinephrine(1 mg/cardiopulmonary resuscitation(CPR) cycle) and Vasopressin(20 international unit(IU)/cardiopulmonary resuscitation(CPR) cycle)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Experimental Group 2
Description: Using Epinephrine(1 mg/cardiopulmonary resuscitation(CPR) cycle) and Steroid(Methylprednisolone, 40 mg at first cycle)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental Group 3
Description: Using Epinephrine(1 mg/cardiopulmonary resuscitation(CPR) cycle), Vasopressin(20 international unit(IU)/cardiopulmonary resuscitation(CPR) cycle) and Steroid(Methylprednisolone, 40 mg at first cycle)
Study: NCT04209920

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CAD-CAM milled PMMA crown
Description: the patient will receive a full coverage restoration for hypomineralized first permanent molar in patient suffering from molar incisor hypomineralization using PMMA disks using a CAD-CAM technology.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cast metal coping using nickel chromium alloy
Description: the patient will receive a full coverage restoration for hypomineralized first permanent molar in patient suffering from molar incisor hypomineralization using Nickel Chromium alloy to make a Cast Coping.
Study: NCT01932034

Intervention type: DEVICE
Intervention: BestDose Computer Software
Description: BestDose is made by the USC Laboratory of Applied Pharmacokinetics. It uses a multiple-model, Bayesian adaptive control algorithm to find the maximally precise dose that will achieve a user-specified target concentration or concentrations.

Intervention type: DEVICE
Intervention: BestDose Computer Software
Description: BestDose is made by the USC Laboratory of Applied Pharmacokinetics. It uses a multiple-model, Bayesian adaptive control algorithm to find the maximally precise dose that will achieve a user-specified target concentration or concentrations.
Study: NCT02687204

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Twice daily enoxaparin prophylaxis
Description: Patients will have peak and trough steady state anti-Xa levels drawn. For patients with out of range peak levels, real time enoxaparin dose adjustment using a clinical protocol will be performed. Repeat steady state levels will be checked.
Study: NCT03024762

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: targeted Provider-Initiated-Testing and Counseling (tPITC)
Description: The intervention arm involves children and adolescents with unknown HIV status, aged between 6 weeks to 19 years, born to parents living with HIV/AIDS. These children will be identified for HIV testing through their parents diagnosed with HIV or receiving HIV care in the hospital.